SCHEMBL27299673

SCHEMBL27299673

CCOC(=O)c1cnc(SCCCOC(=O)c2cnc(SC)nc2Cl)nc1NC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
MAPT P10636 7/20 0.50
SYK P43405 2/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 3/20 0.49
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
FOS P01100 1/20 0.48
JUN P05412 1/20 0.48
MAPK1 P28482 2/20 0.47
HTT P42858 1/20 0.47
HPGD P15428 3/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TDP1 Q9NUW8 2/20 0.43
POLB P06746 1/20 0.43
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29545771 0.83 ALDH1A1 (0.70) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL1521842 0.83 ALDH1A1 (0.70) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL29506595 0.81 MAPT (0.61) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL188686 0.81 MAPT (0.61) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL1014833 0.80 SMN1; SMN2 (0.59) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL28520505 0.79 SMN1; SMN2 (0.68) ALDH1A1MAPTLMNASMN1; SMN2NPC1
SCHEMBL18673593 0.79 MAPT (0.51) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL28456249 0.79 ALDH1A1 (0.58) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL5808541 0.76 MEN1 (0.58) ALDH1A1MAPTSYKLMNASMN1; SMN2
SCHEMBL7017546 0.75 ALDH1A1 (0.54) ALDH1A1MAPTLMNASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023249968-A1 BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-DJPYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed